guanidine has been researched along with bortezomib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Huang, F; Li, D; Liu, J; Shao, S; Shen, Y; Shi, X; Tang, J; Wang, R; Xiang, J; Xu, H; Xu, X; Yao, S; Zhang, W; Zhou, Z | 1 |
1 review(s) available for guanidine and bortezomib
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for guanidine and bortezomib
| Article | Year |
|---|---|
Guanidine-modified nanoparticles as robust BTZ delivery carriers and activators of immune responses.
Topics: Antigens; Bortezomib; Cell Line, Tumor; Drug Carriers; Guanidine; Humans; Immunity; Immunotherapy; Nanoparticles; Neoplasms; Tumor Microenvironment | 2023 |